Austin Duke

Austin Duke

Managing Director atBroadOak Capital PartnersMaryland

Austin Duke is a Managing Director at BroadOak Capital Partners, focusing on venture capital and early-stage healthcare investments. He previously led healthcare venture investments at UnityPoint Health Ventures and served as Chief Science Officer for a neuromodulation company.

What Austin can write

Writes checks ofNot reported
Comes in atNot reportedCan lead the round
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Career

  1. UnityPoint Health Ventures · led healthcare venture capital investments
  2. a neuromodulation company · Chief Science Officer
  3. UnityPoint Health Ventures
  4. BroadOak Capital Partners · Managing Director
    Now

Focus

venture capitalearly-stage investmentshealthcarebiotoolsCGT

Education

North Carolina State University, BS in Biomedical EngineeringVanderbilt University, PhD in Biomedical Engineering

Also at BroadOak Capital Partners

Alert me when BroadOak Capital Partners is active

One email when Austin's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Austin Duke?

Austin Duke is a Managing Director at BroadOak Capital Partners, focusing on venture capital and early-stage healthcare investments. He previously led healthcare venture investments at UnityPoint Health Ventures and served as Chief Science Officer for a neuromodulation company.

How much does Austin Duke invest?

BroadOak Capital Partners has not reported a check size.

How do I pitch Austin Duke?

A warm intro from a founder BroadOak Capital Partners backed works best. A short LinkedIn note with one line on traction is the next best route.

What did Austin Duke do before BroadOak Capital Partners?

led healthcare venture capital investments at UnityPoint Health Ventures; Chief Science Officer at a neuromodulation company; UnityPoint Health Ventures.

Last updated 2026-10-15. Is this you? Ask for a correction.